Pfizer faces showdown with $1.5 billion activist investor after post-Covid share plunge
by from on (#6RDGR)
Pfizer is facing a showdown after a $1.5 billion bid to revive the company's post-Covid share plunge took a highly inappropriate, flagrantly unethical" twist.